Prognostic significance of cardiac biomarkers in patients with AL amyloidosis treated with a daratumumab-based regimen

Amyloid 2026

View at publisher
Authors: Taku Kikuchi, U Kondo, Shotaro Sugita, Miyu Watanabe, Chiaki Matsumoto, Moe Nomura‐Yogo, Kodai Kunisada, Kota Sato, Tomomi Takei, Mizuki Ogura, Yu Abe, Osamu Hosoya
+2 more Tadao Ishida, Nobuhiro Tsukada
DOI: 10.1080/13506129.2025.2611254
Cited by: 0
References: 13

Abstract

Daratumumab-based therapy has improved overall survival in patients with AL amyloidosis; however, the incidence of serious adverse events increases with advancing cardiac stage, and the European 20...

Fields of Study & Subjects

Amyloidosis: Diagnosis Treatment Outcomes Takotsubo Cardiomyopathy and Associated Phenomena Pericarditis and Cardiac Tamponade

Publication details

Journal / source
Amyloid
Volume
33
Issue
1
Pages
112–116
Publication date
2 January 2026
Language
EN